Literature DB >> 31690482

Renaissance of Allostery to Disrupt Protein Kinase Interactions.

Alejandro E Leroux1, Ricardo M Biondi2.   

Abstract

Protein-protein interactions often regulate the activity of protein kinases by allosterically modulating the conformation of the ATP-binding site. Bidirectional allostery implies that reverse modulation (i.e., from the ATP-binding site to the interaction and regulatory sites) must also be possible. Here, we review both the allosteric regulation of protein kinases and recent work describing how compounds binding at the ATP-binding site can promote or inhibit protein kinase interactions at regulatory sites via the reverse mechanism. Notably, the pharmaceutical industry has been developing compounds that bind to the ATP-binding site of protein kinases and potently disrupt protein-protein interactions between target protein kinases and their regulatory interacting partners. Learning to modulate allosteric processes will facilitate the development of protein-protein interaction modulators.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  allostery; bidirectional allostery; protein kinase; protein kinase regulation; protein–protein interaction

Mesh:

Substances:

Year:  2019        PMID: 31690482     DOI: 10.1016/j.tibs.2019.09.007

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  10 in total

Review 1.  The Tails of Protein Kinase A.

Authors:  Susan S Taylor; Kristoffer Søberg; Evan Kobori; Jian Wu; Sabine Pautz; Friedrich W Herberg; Bjørn Steen Skålhegg
Journal:  Mol Pharmacol       Date:  2021-07-30       Impact factor: 4.054

2.  Conformational Selection Mechanism Provides Structural Insights into the Optimization of APC-Asef Inhibitors.

Authors:  Xinheng He; Ning Huang; Yuran Qiu; Jian Zhang; Yaqin Liu; Xiao-Lan Yin; Shaoyong Lu
Journal:  Molecules       Date:  2021-02-11       Impact factor: 4.411

3.  CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cells.

Authors:  Raoud Marayati; Laura L Stafman; Adele P Williams; Laura V Bownes; Colin H Quinn; Hooper R Markert; Juliet L Easlick; Jerry E Stewart; David K Crossman; Elizabeth Mroczek-Musulman; Elizabeth A Beierle
Journal:  Cancer Gene Ther       Date:  2021-04-16       Impact factor: 5.854

4.  Discovery of a tetrahydroisoquinoline-based CDK9-cyclin T1 protein-protein interaction inhibitor as an anti-proliferative and anti-migration agent against triple-negative breast cancer cells.

Authors:  Shasha Cheng; Guan-Jun Yang; Wanhe Wang; Dik-Lung Ma; Chung-Hang Leung
Journal:  Genes Dis       Date:  2021-07-10

5.  Discovery of cryptic allosteric sites using reversed allosteric communication by a combined computational and experimental strategy.

Authors:  Duan Ni; Jiacheng Wei; Xinheng He; Ashfaq Ur Rehman; Xinyi Li; Yuran Qiu; Jun Pu; Shaoyong Lu; Jian Zhang
Journal:  Chem Sci       Date:  2020-11-02       Impact factor: 9.825

6.  Untangling Dual-Targeting Therapeutic Mechanism of Epidermal Growth Factor Receptor (EGFR) Based on Reversed Allosteric Communication.

Authors:  Yuran Qiu; Xiaolan Yin; Xinyi Li; Yuanhao Wang; Qiang Fu; Renhua Huang; Shaoyong Lu
Journal:  Pharmaceutics       Date:  2021-05-18       Impact factor: 6.321

7.  Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1T315I and BCR-ABL1T315I-E255K.

Authors:  Afsar Ali Mian; Isabella Haberbosch; Hazem Khamaisie; Abed Agbarya; Larissa Pietsch; Elizabeh Eshel; Dally Najib; Claudia Chiriches; Oliver Gerhard Ottmann; Oliver Hantschel; Ricardo M Biondi; Martin Ruthardt; Jamal Mahajna
Journal:  Ann Hematol       Date:  2021-06-10       Impact factor: 3.673

8.  Synergistic Allostery in Multiligand-Protein Interactions.

Authors:  Abhijeet Ghode; Lissy Z F Gross; Wei-Ven Tee; Enrico Guarnera; Igor N Berezovsky; Ricardo M Biondi; Ganesh S Anand
Journal:  Biophys J       Date:  2020-09-28       Impact factor: 4.033

Review 9.  ACE2, the Receptor that Enables Infection by SARS-CoV-2: Biochemistry, Structure, Allostery and Evaluation of the Potential Development of ACE2 Modulators.

Authors:  Lissy Z F Gross; Mariana Sacerdoti; Albrecht Piiper; Stefan Zeuzem; Alejandro E Leroux; Ricardo M Biondi
Journal:  ChemMedChem       Date:  2020-08-11       Impact factor: 3.540

10.  A Tetratricopeptide Repeat Scaffold Couples Signal Detection to OdhI Phosphorylation in Metabolic Control by the Protein Kinase PknG.

Authors:  María-Natalia Lisa; Adrià Sogues; Nathalie Barilone; Meike Baumgart; Magdalena Gil; Martín Graña; Rosario Durán; Ricardo M Biondi; Marco Bellinzoni; Michael Bott; Pedro M Alzari
Journal:  mBio       Date:  2021-10-05       Impact factor: 7.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.